Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OXIGENE INC. (OXGN) -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (219)	6/7/2001 1:33:20 PM
From: keokalani'nui	Read Replies (1) \| Respond to of 273

What a sophomoric PR today. Looking more like US-type self-promotion. OXiGENE Completes Transition to Watertown, MA Offices WATERTOWN, Mass., June 7 /PRNewswire/ -- OXiGENE, Inc. (Nasdaq: OXGN, SSE: OXGN) announced today the completion of the transition of its scientific, administrative and financial functions to the Company's Watertown, MA offices. As part of the move, OXiGENE chairman and CEO, Bjorn Nordenvall, M.D., Ph.D., has now relocated to the Watertown offices from Sweden. This move completes a strategic plan announced last October that addresses the continuing growth of the Company as a result of its success in research, discovery and ongoing clinical trials. ``We believe this transition will allow us to raise OXiGENE's profile in the U.S.,'' said Dr. Nordenvall. ``We already enjoy a healthy profile in the European pharmaceutical community, and believe this move will help us gain the same level of recognition in the U.S. pharmaceutical arena. In addition, this move allows management to develop broader relationships within the U.S. investment community and increase our visibility in the global capital markets.'' <I cut the rest> Maybe they could announce the purchase of a few IBM laptops and hyperlink to its NYSE trading symbol.